RNPC3 and cancer: The autoimmune panel indicated elevated anti-ribonucleoprotein (anti-RNP), anti-Sjögren's Syndrome A/Ro (anti-SSA/Ro), anti-topoisomerase I (anti-Scl-70), and anti-Ku antibodies, while key cancer-associated myositis markers were absent.